Blockchain Registration Transaction Record

Scinai Immunotherapeutics Enters $2 Million Investment Commitment Agreement

Scinai Immunotherapeutics (NASDAQ: SCNI) enters into a $2 million Investment Commitment Agreement with RK Stone Miami LLC, demonstrating the company's dedication to developing inflammation and immunology biological products and providing CDMO services.

This news matters because it highlights a significant investment commitment agreement between Scinai Immunotherapeutics and RK Stone Miami LLC, showcasing the company's focus on developing inflammation and immunology biological products and providing CDMO services. The agreement will allow Scinai to issue and sell ASDs to the investor for an aggregate purchase price of up to $2 million, without requiring the company to register for resale the ADSs to be issued under the agreement.